![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Tools
Tools
Preview |
PDF (Original Article)
- Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
1MB |
![[thumbnail of Supplementary Material]](https://edoc.mdc-berlin.de/style/images/fileicons/other.png) |
Other (Supplementary Material)
406kB |
| Item Type: | Article |
|---|---|
| Title: | CRISPR-Cas9 mediated proteinase 3 autoantigen deletion as a treatment strategy for anti-neutrophil cytoplasmic autoantibody-associated vasculitis |
| Creators Name: | Jerke, U., Eulenberg-Gustavus, C., Wagner, D.L., Schreiber, A. and Kettritz, R. |
| Abstract: | INTRODUCTION: Proteinase 3 (PR3) is a major autoantigen in patients with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV). Here, we performed a proof-of-principle study using ex vivo CRISPR-Cas9 guided gene editing to eliminate the PR3 autoantigen as an alternative to suppressing the autoimmune response to PR3. METHODS: A ribonucleoprotein (RNP) complex of Cas9 protein and a PR3-specific single guide-RNA was transfected into human CD34(+) hematopoietic stem and progenitor cells (HSPC) by electroporation. Effects on PR3 protein abundance, neutrophil differentiation, and ANCA-dependent and -independent neutrophil responses were assessed. RESULTS: Gene editing introduced a frame shift in exon 2 of PRTN3. Consequently, PR3 protein was efficiently reduced in neutrophil-differentiated HSPCs as demonstrated by immunoblotting, ELISA, microscopy, and the complete absence of PR3-specific proteolytic activity. Human neutrophil elastase served as control and was not affected. PR3-deleted (PR3(KO))- and PR3 wild-type (PR3(WT))-HSPCs showed similar neutrophil differentiation. Importantly, general neutrophil defense functions to non-ANCA receptor-independent and -dependent stimuli were similar in PR3(KO)- and PR3(WT)-neutrophils as was constitutive apoptosis. Flow cytometry showed that cell membrane-PR3 was significantly reduced on PR3(KO)-neutrophils and consequent neutrophil activation to either monoclonal antibodies to PR3 or human PR3-ANCA was attenuated. In contrast, myeloperoxidase-ANCA stimulation was not affected. CONCLUSIONS: We show the feasibility and efficacy of depleting the PR3 autoantigen in human CD34(+) HSPCs using CRISPR-Cas9. Depleting the PR3 autoantigen instead of suppressing the autoimmune response to PR3 could potentially lead to drug-free remission, particularly in patients with refractory or relapsing disease. |
| Keywords: | ANCA Vasculitis, Autoimmunity, CRISPR-Cas9, Gene Editing, Proteinase 3 |
| Source: | Kidney International |
| ISSN: | 0085-2538 |
| Publisher: | Elsevier / International Society of Nephrology |
| Volume: | 108 |
| Number: | 1 |
| Page Range: | 145-149 |
| Date: | July 2025 |
| Official Publication: | https://doi.org/10.1016/j.kint.2025.03.020 |
| PubMed: | View item in PubMed |
Repository Staff Only: item control page
